Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Onyx Pharmaceuticals reaches target enrollment in ASPIRE trial

Feb. 23, 2012

BMS gains additional indication approvals for two anticancer drugs

Feb. 23, 2012

New signaling pathway inhibitors developed in Sweden

Feb. 23, 2012

Merck KGaA patents new P70S6K inhibitors

Feb. 23, 2012

New site added to phase II trial of Telcyta

Feb. 22, 2012

Nippon Kayaku anticancer drugs approved for additional indications in Japan

Feb. 22, 2012

PCI Biotech begins treatment in Amphinex study

Feb. 22, 2012

Full BOLERO-2 study results published

Feb. 22, 2012

FDA places clinical hold on Capesaris

Feb. 21, 2012

Novel inhibitor of V600-mutant B-raf shows antitumor activity in animal models

Feb. 21, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...